Ryan Module 5 Post Quiz 2023

Quiz Summary

0 of 7 Questions completed

Questions:

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 7 Questions answered correctly

Your time:

You have reached 0 of 0 point(s), (0)

Current
Review
Answered
Correct
Incorrect

Question 1 of 7

1. Question
1. Sonographic features diagnostic of early pregnancy loss include:
- A. Yolk sac greater than 7mm in diameter
- B. Mean sac diameter greater than 16mm with no embryonic pole seen
- C. Crown rump length greater than 7mm with no cardiac activity
- D. (A) and (C) only
- E. (B) and (C) only
Correct

Incorrect
Question 2 of 7

2. Question
2. Considerations for counseling on management options when a woman is experiencing early pregnancy loss include all of the following EXCEPT:
- A. Pregnancy intention
- B. Emotional support system
- C. Provider’s preference for treatment
- D. Family responsibilities
- E. Professional demands
Correct

Incorrect
Question 3 of 7

3. Question
3. For which type(s) of early pregnancy loss is expectant management most successful?
- A. Incomplete miscarriages
- B. EPL with bleeding or cramping
- C. Nonviable embryo discovered weeks after demise
- D. (A) and (C) only
- E. (B) and (C) only
- F. (A) and (B) only
Correct

Incorrect
Question 4 of 7

4. Question
4. Evidence-based dosing for treatment of early pregnancy loss includes:
- A. Mifepristone 200 mg orally, followed by misoprostol 800 mcg vaginally 24-48 hours later
- B. Mifepristone 200 mg orally, followed by misoprostol 400 mcg orally 24-48 hours later
- C. Misoprostol 400 mcg orally, optional repeat dose 24-48 hours later if no initial response
- D. Misoprostol 800 mcg vaginally, optional repeat dose 24-48 hours later if no initial response
- E. (A) and (B) only
- F. (A) and (D) only
- G. All of the above
Correct

Incorrect
Question 5 of 7

5. Question
5. One advantage of medication management over expectant management for EPL is
- A. It can be used for women with intrauterine devices in place
- B. It is safe for women taking anti-coagulants
- C. Increased predictability of bleeding
- D. Decreased likelihood of seeing fetal tissue
Correct

Incorrect
Question 6 of 7

6. Question
6. Patients diagnosed with EPL who have heterogeneous intrauterine material on follow-up ultrasound but report a history of passing the pregnancy tissue and have no continued bleeding always require uterine aspiration.
- A. True
- B. False
Correct

Incorrect
Question 7 of 7

7. Question
7. Which of the following is NOT true about second trimester pregnancy loss:
- A. D&E should always be used for management because it is the safest technique
- B. When managed medically, best evidence supports mifepristone pre-treatment before a misoprostol induction of labor
- C. The most common complication of induction is retained placenta requiring procedural removal
- D. In the absence of maternal health indications, patient preferences should guide management, but inequitable access to both D&E and induction remains a barrier for many
Correct

Incorrect

Ryan Module 5 Post Quiz 2023

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question

6. Question

7. Question